Literature DB >> 24521685

Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy.

Dietmar Georg1, Johannes Hopfgartner2, Joanna Gòra3, Peter Kuess2, Gabriele Kragl3, Daniel Berger2, Neamat Hegazy3, Gregor Goldner2, Petra Georg2.   

Abstract

PURPOSE: To assess the dosimetric differences among volumetric modulated arc therapy (VMAT), scanned proton therapy (intensity-modulated proton therapy, IMPT), scanned carbon-ion therapy (intensity-modulated carbon-ion therapy, IMIT), and low-dose-rate (LDR) and high-dose-rate (HDR) brachytherapy (BT) treatment of localized prostate cancer. METHODS AND MATERIALS: Ten patients were considered for this planning study. For external beam radiation therapy (EBRT), planning target volume was created by adding a margin of 5 mm (lateral/anterior-posterior) and 8 mm (superior-inferior) to the clinical target volume. Bladder wall (BW), rectal wall (RW), femoral heads, urethra, and pelvic tissue were considered as organs at risk. For VMAT and IMPT, 78 Gy(relative biological effectiveness, RBE)/2 Gy were prescribed. The IMIT was based on 66 Gy(RBE)/20 fractions. The clinical target volume planning aims for HDR-BT ((192)Ir) and LDR-BT ((125)I) were D(90%) ≥34 Gy in 8.5 Gy per fraction and D(90%) ≥145 Gy. Both physical and RBE-weighted dose distributions for protons and carbon-ions were converted to dose distributions based on 2-Gy(IsoE) fractions. From these dose distributions various dose and dose-volume parameters were extracted.
RESULTS: Rectal wall exposure 30-70 Gy(IsoE) was reduced for IMIT, LDR-BT, and HDR-BT when compared with VMAT and IMPT. The high-dose region of the BW dose-volume histogram above 50 Gy(IsoE) of IMPT resembled the VMAT shape, whereas all other techniques showed a significantly lower high-dose region. For all 3 EBRT techniques similar urethra D(mean) around 74 Gy(IsoE) were obtained. The LDR-BT results were approximately 30 Gy(IsoE) higher, HDR-BT 10 Gy(IsoE) lower. Normal tissue and femoral head sparing was best with BT.
CONCLUSION: Despite the different EBRT prescription and fractionation schemes, the high-dose regions of BW and RW expressed in Gy(IsoE) were on the same order of magnitude. Brachytherapy techniques were clearly superior in terms of BW, RW, and normal tissue sparing, with lowest values for HDR-BT.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24521685     DOI: 10.1016/j.ijrobp.2013.11.241

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  21 in total

1.  Needle-free cervical cancer treatment using helical multishield intracavitary rotating shield brachytherapy with the 169 Yb Isotope.

Authors:  Karolyn M Hopfensperger; Quentin Adams; Yusung Kim; Xiaodong Wu; Weiyu Xu; Kaustubh Patwardhan; Bounnak Thammavong; Joseph Caster; Ryan T Flynn
Journal:  Med Phys       Date:  2020-03-13       Impact factor: 4.071

Review 2.  Proton therapy for prostate cancer: current state and future perspectives.

Authors:  Yao-Yu Wu; Kang-Hsing Fan
Journal:  Br J Radiol       Date:  2021-09-24       Impact factor: 3.039

3.  Scanned ion beam therapy for prostate carcinoma: Comparison of single plan treatment and daily plan-adapted treatment.

Authors:  Sebastian Hild; Christian Graeff; Antoni Rucinski; Klemens Zink; Gregor Habl; Marco Durante; Klaus Herfarth; Christoph Bert
Journal:  Strahlenther Onkol       Date:  2015-11-27       Impact factor: 3.621

Review 4.  Chronic radiation proctitis: tricks to prevent and treat.

Authors:  Ben G L Vanneste; Lien Van De Voorde; Rogier J de Ridder; Evert J Van Limbergen; Philippe Lambin; Emile N van Lin
Journal:  Int J Colorectal Dis       Date:  2015-07-23       Impact factor: 2.571

Review 5.  High-dose-rate brachytherapy boost for prostate cancer: rationale and technique.

Authors:  Gerard C Morton
Journal:  J Contemp Brachytherapy       Date:  2014-10-06

6.  Multi-axis dose accumulation of noninvasive image-guided breast brachytherapy through biomechanical modeling of tissue deformation using the finite element method.

Authors:  Mark J Rivard; Hamid R Ghadyani; Adam D Bastien; Nicholas N Lutz; Jaroslaw T Hepel
Journal:  J Contemp Brachytherapy       Date:  2015-02-17

Review 7.  Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?

Authors:  Ben G L Vanneste; Evert J Van Limbergen; Emile N van Lin; Joep G H van Roermund; Philippe Lambin
Journal:  Biomed Res Int       Date:  2016-12-28       Impact factor: 3.411

8.  A planning study of focal dose escalations to multiparametric MRI-defined dominant intraprostatic lesions in prostate proton radiation therapy.

Authors:  Tonghe Wang; Jun Zhou; Sibo Tian; Yinan Wang; Pretesh Patel; Ashesh B Jani; Katja M Langen; Walter J Curran; Tian Liu; Xiaofeng Yang
Journal:  Br J Radiol       Date:  2020-01-06       Impact factor: 3.039

9.  Visualizing the urethra by magnetic resonance imaging without usage of a catheter for radiotherapy of prostate cancer.

Authors:  Takaaki Yoshimura; Kentaro Nishioka; Takayuki Hashimoto; Taro Fujiwara; Kinya Ishizaka; Hiroyuki Sugimori; Shoki Kogame; Kazuya Seki; Hiroshi Tamura; Sodai Tanaka; Yuto Matsuo; Yasuhiro Dekura; Fumi Kato; Hidefumi Aoyama; Shinichi Shimizu
Journal:  Phys Imaging Radiat Oncol       Date:  2021-03-26

10.  A treatment planning study comparing tomotherapy, volumetric modulated arc therapy, Sliding Window and proton therapy for low-risk prostate carcinoma.

Authors:  Sergiu Scobioala; Christopher Kittel; Nicolas Wissmann; Uwe Haverkamp; Mohammed Channaoui; Omar Habibeh; Khaled Elsayad; Hans Theodor Eich
Journal:  Radiat Oncol       Date:  2016-09-27       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.